Eli Lilly Antibody Drug Combo For COVID-19 Gets FDA Emergency Approval By: TalkMarkets February 10, 2021 at 07:23 AM EST Eli Lilly’s antibody treatments have received an emergency use authorization from the United States Food and Drug Administration. Read More >> Related Stocks: Eli Lilly Gilead Sciences Regeneron Pharmaceuticals